Neuropsychiatric Model of Addiction Simplified<br>Pharmacotherapy of Opioid Use Disorder—Update and Current Challenges<br>Policy Ahead of the Science: Medical Cannabis Laws Versus Scientific Evidence<br>Practical Considerations for Treating Comorbid Posttraumatic Stress Disorder in the Addictions Clinic: Approaches to Clinical Care, Leadership, and Alleviating Shame<br>Kratom: Substance of Abuse or Therapeutic Plant?<br>Important Drug-Drug Interactions for the Addiction Psychiatrist<br>Nicotine Addiction: A Burning Issue in Addiction Psychiatry<br>Substance Use Disorders in Postacute and Long-Term Care Settings<br>Update on Gambling Disorder<br>Attention-Deficit Hyperactivity Disorder and Therapeutic Cannabis Use Motives<br>Practical Technology for Expanding and Improving Substance Use Disorder Treatment: Telehealth, Remote Monitoring, and Digital Health Interventions<br>Harm Reduction: Not Dirty Words Any More<br>Individual Paths to Recovery from Substance Use Disorder (SUD): What Are the Implications of the Emerging Recovery Evidence Base for Addiction Psychiatry and Practice?<br>The Protective Wall of Human Community: The New Evidence on the Clinical and Public Health Utility of Twelve-Step Mutual-Help Organizations and Related Treatments<br>Technological Addictions<br>Thirty Years of The ASAM Criteria: A Report Card